We would love to hear your thoughts about our site and services, please take our survey here.
US10247730B2
US20170246254A1
Combine these and you pretty much get Traumakine.
Take it easy :D don't go down on high BP now
Careful what you say, Zen, T-kine is not, and will not be a vaccine for the virus (or any virus). It's the one and only solution to the ARDS endgame keeping the lung integrity and preventing the fluid build up, and eventually death. You know this.
Have people forgotten that Traumakine never was even meant for just Covid-19; it's a bonus, if the REMAP part is done fast enough, but still I'd call it almost irrelevant.
Itsall, it definitely came to my mind too that they might not be aiming to get a partner with T-kine after all. Things have taken practically a 360 turn to moonwalking out with REMAP; now that their clinical trial III vol.2 (practically) is free and many of the potential risks of private funded trials averted. It is also very rare for clinical trials to be redone after a failure (we should all know about by now). All of this make the whole situation with Faron and Traumakine quite unique.
Sry for ranting
Applting your logic Pots, which is more dangerous; a logical and well informed looking post coming straight out of someone's ass or blatant hyping? This is not a place to hold anyone's hand or to teach any official knowhow about anything. Everything comes 'as is'. If some aspiring investor fools himself to thinking "this must be the jackpot, lucky me" because of some post on an investment forum then it's not much different from tips given on a blackjack casino forum. "Do your own research, and make your own plan" is the bare minimum what is needed to begin investing. There's always lazy people who will burn their fingers as they don't bother to have an effort; why else casinos and gambling are so popular? In my work I see magnificently high educated people providing knowhow and 'facts' out of their asses all the time. Everyone believes every word on the spot, because why wouldn't they? Later it is revealed that the data presenter had greatly misundeststood something and all was just *******s. Millions of euros are lost in a year in pursuit of ghosts and shadows that don't exist. That being said, I agree that Sax's posts are on the spot!
Pot_Odds, this is a Faron Pharmaceuticals share chat message board, ofc people have an agenda here (wtf??). What I (personally) don't understand, are the messages where some blame is tossed around as if some kind of scheduled milestones of the share price would be missed. Like really, we're all big boys and girls here so take responsibility of your own finances. This is NOT a private message board of investment professionals on anyone's payroll; not a single person is responsible for your interest in investing or investment in Faron but you (and if you're not interested in investing Faron then wtf are you doing here?). Blaming people of "hyping it up" when prices don't jump in one week's (or w/e) time is just.. leaves me speechless. Investing is not for everyone.
I find it amusing that people here throw around blame for not following THEIR OWN investment strategy. Do a plan and follow it, if things change in your opinion, change your plan.
https://youtu.be/N5KEbdFaX-c?t=51
I think this was the "teaser" presentation, mentioned in 1:05.
It is their next substance that will go to trials, but has not any name attached to it quite yet. I think it was mentioned first in one of the presentations in some conference or similar. But the main thing is that it is not just a fabrication made by this board.
Sadly I was out of cash today, would've been easy buys.
My brain made a somersault when I saw that 215 price.. LSE going bananas today, and still at it.
Companies in the bio/medical field don't really get "bought up" unless there are some insurmountable problems regarding the trials, products, monetization etc. Why would the owners sell the potential of a successful company? In this field success means billions or tens of billions of revenue on a yearly basis. Selling usually means that the company faced a dead end and the big owners want out to recoup some of the losses by selling the patents and other assets that still hold value to someone; usually some big pharma that has money to develop the intellectual properties further into a monetizable form.
"state level medicine advances very slowly and with great caution, even during a crisis."
Because it's all still mostly politics..
Drugs that are already on the market may be called using their brand names.
Sax is correct. "Traumakine" is merely a registered trademark owned by Faron Pharmaceuticals. There is still no official "medicine" called Traumakine, because the trials are still ongoing. Traumakine is also Faron's own work name for the interferon beta 1a based treatment we all know so well (for simplicity and publicity). However, all of this means that in these pneumonia trials "Traumakine-treatment" wont be called as that, because officially it does not exist.
There seem to be some confusion for some people about what medical trial at phase III actually means. A substance going to phase III has already been proven to work, small time, regarding the issue it's meant to affect. Traumakine has already went through a phase III trial, where the problem of ineffectiveness was raised; a result that was on the contrary to the phase II trial results. The result of ineffectiveness was put to question, as it was caused by interfering corticosteroids used during the trial III. I wouldn't question Traumakine's effectiveness in treating what is supposed to treat. What trial III's usually bring about, are the myriad possible side effects of the drugs, which may be found to be more severe than previously though (in shorter small time trials). I don't think this is an issue at all regarding Traumakine as interferon beta 1a has been studied and trialled through and through long ago.
C'mon AIMer's, don't let your stock go out so easily
I finally got to watch the interview, and I gotta say, how he came about as a Finn to another Finn.. I felt shivers down my spine. I think he 100% truthful about having full confidence on Traumakine's chances. That was a rare moment coming from a team leader of that calibre, and I work for the biomedical industry..